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Enhanced biostability and cellular uptake of zinc
oxide nanocrystals shielded with a phospholipid
bilayer†
B. Dumontel,‡a M. Canta,‡a H. Engelke, b A. Chiodoni, c L. Racca,a A. Ancona,a
T. Limongi, a G. Canavese ac and V. Cauda *ac
The widespread use of ZnO nanomaterials for biomedical applications, including therapeutic drug
delivery or stimuli-responsive activation, as well as imaging, imposes a careful control over the colloidal
stability and long-term behaviour of ZnO in biological media. Moreover, the effect of ZnO
nanostructures on living cells, in particular cancer cells, is still under debate. This paper discusses the
role of surface chemistry and charge of zinc oxide nanocrystals, of around 15 nm in size, which
influence their behaviour in biological fluids and effect on cancer cells. In particular, we address this
problem by modifying the surface of pristine ZnO nanocrystals (NCs), rich of hydroxyl groups, with
positively charged amino-propyl chains or, more innovatively, by self-assembling a double-lipidic
membrane, shielding the ZnO NCs. Our findings show that the prolonged immersion in simulated
human plasma and in the cell culture medium leads to highly colloidally dispersed ZnO NCs only when
coated by the lipidic bilayer. In contrast, the pristine and amine-functionalized NCs form huge
aggregates after already one hour of immersion. Partial dissolution of these two samples into potentially
cytotoxic Zn2+ cations takes place, together with the precipitation of phosphate and carbonate salts on
the NCs’ surface. When exposed to living HeLa cancer cells, higher amounts of lipid-shielded ZnO NCs
are internalized with respect to the other samples, thus showing a reduced cytotoxicity, based on the
same amount of internalized NCs. These results pave the way for the development of novel theranostic
platforms based on ZnO NCs. The new formulation of ZnO shielded with a lipid-bilayer will prevent
strong aggregation and premature degradation into toxic by-products, and promote a highly efficient
cell uptake for further therapeutic or diagnostic functions.
Introduction
The use of zinc oxide (ZnO) based nanoplatforms in biomedical
applications is constantly increasing over time, thanks to
several useful therapeutic and diagnostic functions of ZnO.1–6
Among them, photodynamic properties and rapid dissolution
enhancing cytotoxicity or drug delivery were tested toward
cancer cells,7 as well as green fluorescent emission strategies
for bioimaging purposes.8 The current challenges for using
ZnO as a theranostic tool include tailoring its nanoscale
morphology, in terms of size, shape,9 aspect ratio,9–13 surface
area,12 and most importantly its surface chemistry,14 to meet
the desired biomedical application. For this reason, it is a
prerequisite to have stable and colloidally dispersed ZnO in
aqueous biological media. Actually, nano-sized and well-
dispersed particles should have dimensions comparable to
naturally occurring biological molecules, allowing their inter-
nalization into cells15 and enabling them to act as bio-imaging
tools or to potentially affect the cellular behaviour in a
therapeutic perspective.
It has been largely demonstrated from in vivo experiments
that the size and surface chemistry of nanoparticles govern
their site of accumulation and action in living organisms.15
In the same way, it is known that the main cytotoxicity
mechanisms of ZnO are related to the capability of the nano-
structure to dissolve and to be internalized by cells.16,17 Since
cell uptake is significantly influenced by the surface chemistry
and size of ZnO nanoparticles, it turns out that the precise
control of both parameters is fundamental.
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Concerning the surface chemistry, pristine ZnO nano-
particles’ surface exposes neutral hydroxyl groups, which basically
govern the surface charge behaviour.13,18 In a high pH aqueous
medium, the chemisorbed protons (H+) leave the NP’s outer layer
inducing a negatively charged surface with partially bonded
oxygen atoms (ZnO). On the other side, for low pH values,
protons from the medium are most likely transferred to the
particle surface, leading to positively charged ZnOH+2 groups.
19
ZnO nanoparticles, characterized by an isoelectric point around
pH 9–10, have a positive surface charge20 under physiological
conditions. Cancer cells usually have high negative membrane
potentials due to the presence of anionic phospholipids, charged
proteins and carbohydrates21 on their outer plasmamembrane.22,23
Therefore, electrostatic interactions with positively charged ZnO
nanoparticles would be expected to enhance the uptake of ZnO
nanoparticles into tumor cells, thus affecting their viability.24
Charge and surface chemistry influence also the colloidal
stability of nanoparticles, a crucial property for their interaction
with biological systems. The presence of capping agents or
coatings enables a precise control in this regard.11 Different
approaches were used to enhance biocompatibility and
decrease nanoparticles’ aggregation, based on polymeric coatings,
such as polyethylene glycol (PEG),25 propylene glycol,10 poly-N-
vinyl-2-pyrrolidone (PVP) and others.26 However, the literature has
also shown the effect of some of these stabilizers on the cytotoxi-
city of ZnO NPs.27
In general, several mechanisms of ZnO NPs’ cytotoxicity were
proposed. Some of them include ZnO nanoparticles’ internalization
inducing reactive oxygen species (ROS)28,29 and DNA damage,14,30
zinc ion release due to nanoparticles’ dissolution,31–35 and
membrane dysfunction.25,36 Nevertheless, in most cases, it is
unclear if ZnO dissolution occurs in the extracellular medium
before cellular uptake or intracellularly after the internalization.
Certain works indicate that the ZnO cytotoxicity is independent of
the concentration of extracellular soluble Zn2+ in the culture
medium37–39 and that a direct particle–cell contact or internaliza-
tion is required for cellular toxicity.40
In agreement with other authors,41 we believe that the poor
accordance between the literature results derives from a lack of
control of the synthetic process, together with a large uncer-
tainty about the surface chemistry and charge, as well as the
wide size distribution of the NPs. To address these issues, in
the present paper we propose a systematic approach to study
the ZnO colloidal stability and cytotoxicity as a function of
different and controlled surface treatments. We designed three
types of ZnO nanocrystals (NCs) with different surface charge
densities and chemistries: (i) bare ZnO NCs rich in hydroxyl
groups, (ii) amino-propyl surface-functionalized ZnO NCs
aiming at a predominant positive surface charge, and (iii)
lipid-coated ZnO NCs for improving colloidal and chemical
stability in biological media. We studied and tuned the colloidal
stability in terms of long-lasting well-dispersed ZnO NC suspen-
sions in different simulated body fluids for both in vitro and
in vivo applications. In particular, we tested the three types of
ZnO NCs in the cell culture medium and in a buffered solution
mimicking the inorganic composition of the human plasma.
We observed a profound effect of the ZnO NCs’ surface
properties on the cellular internalization and cytotoxicity profiles
in in vitro cancer cells. Therefore, the precise control of ZnO
nanoparticles’ surface is crucial to customize and develop new
opportunities in cancer diagnosis and therapies. In detail, we
demonstrate that engineering the surface of ZnO NCs with a
shielding lipidic bilayer leads to a profound enhancement of the
colloidal and chemical stability in biological and simulated
media. Moreover, these properties are related to a reduced
cytotoxicity and to an appreciable enhancement of cellular
internalization of this novel hybrid nanoconstruct.
Our results are therefore of paramount importance to
further improve advanced nano-imaging solutions and to design
alternative therapeutic plans through the use of ZnO NCs when
administered to cancer cells.
Experimental
Synthesis of ZnO nanocrystals
Pristine zinc oxide nanocrystals (ZnO NCs) were synthetized
by a wet chemical method using zinc acetate dihydrate
(Zn(CH3COO)2H2O) and sodium hydroxide (NaOH) as precursors
and methanol as a solvent. In detail, 0.818 g (3.73 mmol) of
Zn(CH3COO)2H2O was dissolved in 42 mL of methanol in a
100 mL round bottom flask and heated to 60 1C under vigorous
stirring. When the temperature reached 60 1C, 318 mL of
bi-distilled water (from a Direct Q3 system, Millipore) and a
solution of 0.289 g (7.22 mmol) of NaOH in 23 mL of methanol
were dropwise added to the zinc acetate solution. The resulting
synthesis mixture was maintained, under continuous stirring,
at 60 1C for 2.15 h and then washed two times with fresh
ethanol using a repeated centrifugation–redispersion process.
Preparation of ZnO–NH2 nanocrystals
The amino-propyl functionalized sample (ZnO–NH2 NCs) was
obtained by the reaction of pristine zinc oxide nanocrystals and
3-aminopropyltrimethoxysilane (APTMS) as follows: 100 mg
(1.23 mmol) of ZnO NCs, dispersed in ethanol, was heated to
78 1C in a 100 mL flask under continuous stirring and a
nitrogen gas flow. After about 15 minutes, 21.4 mL of APTMS
was added to the solution; this volume of the functionalizing
agent corresponds to 0.123 mmol (22.05 g), equal to 10 mol% of
total ZnO amount. The obtained mixture was refluxed under a
nitrogen gas flow for 6 h and then washed two times to remove
the unbound APTMS molecules.
Preparation of ZnO–DOPC nanocrystals
To prepare lipid-coated nanocrystals (ZnO–DOPC NCs), a
solvent exchange method was used. 2.5 mg of DOPC (1,2-dioleoyl-
sn-glycero-3-phosphocholine) in chloroform was dried under
vacuum overnight and re-dispersed in a 1 mL mixture of
40 vol% ethanol and 60 vol% bi-distilled water. Afterwards, a
volume corresponding to 1 mg of ZnO NCs was centrifuged, in
order to remove all the ethanol, and then the pellet was
suspended in 100 mL of lipid solution. The addition of water
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(700 mL) results in the formation of a supported lipid bilayer on
the surface of ZnO NCs. The obtained ZnO–DOPC NCs were
washed with water two times to remove the unbound lipids. For
the bio-stability assays, the whole procedure was scaled-up to
obtain 100 mg of ZnO–DOPC NCs. For lipid-coated nanocrystals
used in the fluorescence experiments, two labelling steps were
added: liposomes were labeled with Bodipy-FL-DHPE by adding
0.5 mg of fluorescent dye at 2.5 mg of lipids before evaporating
the chloroform. Amino-propyl functionalized nanocrystals
(ZnO–NH2 NCs) were coupled with ATTO550-NHS ester dye,
at a ratio of 2 mg per mg of NCs. The suspension of dye and
ZnO–NH2 NCs in ethanol was kept in the dark under contin-
uous stirring overnight and then the sample was washed two
times with fresh ethanol in order to remove the unbound dye
molecules.
Bio-stability assays
For the bio-stability assays, the three types of ZnO nanocrystals
were tested in Simulated Body Fluid (SBF), and cell culture
medium (EMEM) completed with 10% of fetal bovine serum.
To prepare the SBF, the following reagents were dissolved in
500 mL of bi-distilled water: 7.996 g NaCl, 0.350 g NaHCO3,
0.224 g KCl, 0.228 g K2HPO43H2O, 0.305 g MgCl26H2O,
0.278 g CaCl2, 0.071 g Na2SO4, 40 mL HCl 1 M, and 6.057 g
NH2C(CH2OH)3 (TRIS). The pH of the solution was then regu-
lated at 7.4 at 37 1C and the solution was made up to 1.0 L and
stored at 4 1C until use.
The bio-stability tests were performed at a concentration of
2 mg mL1, by suspending 25 mg of each ZnO NC sample
(opportunely separated from ethanol or water with a centri-
fugation and washing step) in 12.5 mL of SBF or EMEM
pre-heated at 37 1C. The samples were maintained under
continuous stirring (150 rpm) at a constant temperature of
37 1C. At selected times (1, 24, 72 h and 25 days), 2.5 mL of the
suspension was collected and centrifuged. The supernatant was
collected and opportunely diluted for ICP-MS analysis, whereas
the ZnO NCs were washed with bi-distilled water twice and
characterized.
Physico-chemical characterization
The particle size and Zeta potential of the three samples were
determined using dynamic light scattering (Zetasizer Nano
ZS90, Malvern). DLS measurements were performed by suspend-
ing 500 mg of nanoparticles in 1 mL of various tested media
(ethanol, water, SBF or EMEM). Zeta potential measurements
were performed in bi-distilled water and the pH was adjusted
with HCl and NaOH 1 M.
The morphology of the nanocrystals was studied by Field
Emission Scanning Electron Microscopy (FESEM, Auriga and
Merlin, Karl Zeiss) and Transmission Electron Microscopy
(TEM, Tecnai F20ST, FEI) before and after the bio-stability
assays. The samples were prepared by diluting 5 mL of nano-
crystals’ suspension in bi-distilled water (final concentration
25 mg mL1) and drying a drop of the resulting suspension on a
silica wafer or on a holey carbon-coated copper grid for FESEM
and TEM, respectively.
Fourier transform infrared spectra (FT-IR, recorded in
transmission mode with a Bruker Equinox 55 in the region of
4000–400 cm1) and energy dispersive spectra (EDS, Oxford
Instruments, coupled to the FESEM Merlin, Karl Zeiss) were
recorded in order to verify the success of functionalization
procedures and to establish the precipitation of organic and
inorganic compounds and their nature during bio-stability
assays.
The formation of the supported lipid bilayer on the surface
of ZnO–DOPC samples was also confirmed by fluorescence
co-localization experiments. A fully motorized wide-field
inverted microscope (Eclipse TiE from Nikon) equipped with
a high resolution sCMOS camera (Zyla 4.2 Plus from Andor) was
used with an immersion-oil 60 objective.
The crystalline structure of the material was analysed by
X-ray diffraction using an X’Pert diffractometer with y–2y Bragg–
Brentano configuration using Cu-Ka radiation (l = 1.54 Å, 40 kV
and 30 mA). The spectra were collected in the range of 20–601
after each bio-stability assay step, in order to verify the preserva-
tion of nanoparticles’ crystalline structure and the presence of
crystalline precipitates.
Internalization experiments in HeLa cells
For cell experiments, HeLa cells (ATCCs CCL-2) were cultivated
in DMEM supplemented with 10 vol% FBS and 1 vol% Pen-
Strep. All reagents were purchased from Sigma-Merck.
The day before particle incubation the cells were seeded
onto 8-well ibiTreat slides (Ibidi) at a concentration of 5000
cells per well containing 300 mL of medium. They were incu-
bated with the NCs at a final concentration of 18 mg mL1 for
24, 48 and 72 h. NCs were prepared and labelled as described
above, only replacing Atto550 by Atto633 NHS ester dye. After
incubation for 24–72 h, the cell membrane was stained imme-
diately before imaging using WGA488 (Thermofisher Scientific)
and washed with the medium after an incubation period of
about 1 minute. Cells and particles were imaged at 37 1C under
a 5% CO2 humidified atmosphere using spinning disc micro-
scopy (Zeiss Cell Observer SD utilizing a Yokogawa spinning
disk unit CSU-X1). The objective was a 1.40 NA 63 Plan
apochromat oil immersion objective (Zeiss). Atto633 was
imaged with 639 nm and WGA488 with 488 nm laser excitation.
For two colour detection a dichroic mirror (560 nm, Semrock)
and band-pass filters 525/50 and 690/60 (both Semrock) were
used in the detection path. Separate images for each fluores-
cence channel were acquired using two separate electron multi-
plier charge coupled device (EMCCD) cameras (Photometrics
Evolve TM).
The stacks of confocal fluorescence images of cells inter-
acting with nanoparticles were analysed applying the Particle_in_
Cell-3D plugin based on the ImageJ software and free to download
at the ImageJ Documentation Portal.42 For each experimental
condition, 13 cells were randomly selected from the confocal
z-stacks and independently analysed. The fluorescence image of
the cell membrane in each confocal plane was transformed into a
3D mask of the cell.
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By applying this mask to the corresponding particle fluores-
cence images, intra- and extra-cellular nanoparticles were auto-
matically discriminated. To get a semiquantitative result, for
each cell the sum of all pixel intensities corresponding to the
intracellular nanoparticle fluorescence signal was finally calcu-
lated and then averaged over all cells corresponding to the
same experimental condition. The fluorescence intensity
threshold of nanoparticles was kept constant for all the stacks.
Cytotoxicity experiments
HeLa cells were seeded at a concentration of 5000 cells per well
into 96 well plates (Corning) containing a final volume of 100 mL
of medium. One day after seeding they were incubated with NCs
at the desired concentration. 72 h after incubation with NCs,
MTT tests were performed according to the standard protocol.
Results and discussion
Zinc oxide nanocrystals
For this study, we selected a wet chemical route for obtaining
small ZnO nanocrystals (ZnO NCs) with a spherical shape, as
reported in detail in the Experimental section. A fast synthetic
approach, modified from that already reported in the
literature,43 was applied involving zinc acetate dihydrate and
sodium hydroxide in a molar ratio Zn2+ : OH of 1 : 1.94 and in
polar methanol solvent at mild temperature (60 1C) according
to the following chemical reactions:
Zn2+ + 2OH- Zn(OH)2
Zn(OH)2 + 2OH
- Zn(OH)4
2
Zn(OH)4
2- ZnO + H2O +2OH

We obtained spherical shaped, well-dispersed nanocrystals
having a size of about 14 nm in diameter (Fig. 1a, measured
from Field Emission Scanning Electron Microscopy (FESEM)
with the application of a thin Pt conductive layer.). Both
Transmission Electron Microscopy (TEM) and Scanning Trans-
mission Electron Microscopy (STEM) also confirmed the round
shape of the ZnO NCs and their size (Fig. 1a). The literature
indicates indeed to maintain the Zn2+ : OH molar ratio
between 1 : 1.6 and 1 : 1.95 to obtain ZnO particles with a
diameter below 15 nm. The X-ray diffraction pattern (Fig. S1
in the ESI†) shows that the ZnO NCs are in the single-phase
wurtzite crystalline structure (according to the JCPDS 36-1451,
hexagonal, space group P63mc). The Debye–Scherrer equation
applied to the broad diffraction peaks confirms the average size
of nanocrystallites, being around 15 nm. After functionalization
with either aminopropyl groups (ZnO–NH2 in Fig. 1b) or the
lipid layer (ZnO–DOPC in Fig. 1c), the morphology and the
crystalline structure of the NCs are not modified (Fig. S1 in
the ESI†), except in the size of the ZnO–DOPC sample, which
presents larger particles of around 20 nm.
We can suppose the formation of a supported lipid bilayer of
a few nm in thickness on the surface of ZnO NCs, as previously
reported by some of us using the solvent-exchange methods
applied to a lipid solution in the presence of mesoporous silica
nanoparticles.44 The approach relies on the effects that a
Fig. 1 The three ZnO nanocrystals used in this study: (a) pristine ZnO NCs, (b) amine-propyl functionalized ZnO–NH2 NCs, and (c) lipid-coated
ZnO–DOPC NCs. From left to right: scheme of the particles, FESEM, TEM and STEM images for each NC type. For FESEM images all the NCs were coated
by a thin layer of Pt. The scale bar is 50 nm in all FESEM and TEM images, whereas it is 20 nm in all the three STEM images (right column).
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solvent has on the self-assembly behaviour of lipids. Since the
interaction between lipid molecules and alcoholic solutions
(ethanol or isopropanol) is favourable, the lipids are solvated
and exist as monomers at low water concentrations. However,
by adding water to the solution, the lipids begin to self-
assemble into liposomes, constituted by a lipid bilayer.45 In
this arrangement, the hydrophobic tails of the lipids are
protected from water. A similar behaviour is observed in the
presence of the surface of a nanoparticle, which offers a
favourable support for the lipid bilayer self-assembly.44
The successful functionalization procedure of pristine ZnO,
leading to ZnO–NH2 and ZnO–DOPC, is supported by both
Fourier Transform-InfraRed (FT-IR) and Z-potential analyses.
The FT-IR spectra (Fig. 2a) of ZnO and ZnO–NH2 nanocrystals
show in general some common features among the two differ-
ent ZnO samples, such as an intense mode at 440 cm1 typical
of Zn–O vibration and a broad band from 3600 to 3200 cm1,
which is due to the stretching vibration of hydroxyl groups on
the ZnO surface. In addition, the two spectra show with different
intensities the CQO and C–O vibration modes at 1570 and
1420 cm1, as well as the symmetric and antisymmetric
stretching of –CH2 and –CH3 groups at 2860 and 2925 cm
1,
respectively. These vibrations are attributed to residual acetate
groups on the ZnO surface due to the precursors used or to
methoxy groups derived from the reflux conditions, used in the
synthetic procedure.46 However, in the case of ZnO–NH2 NCs,
the 2860 and 2925 cm1 stretching modes are more intense
because of the presence of the propyl chain of the amine-
functional group, thus confirming the successful functionaliza-
tion of the ZnO surface. The ZnO–NH2 NCs’ spectrum also shows
an absorption peak near 3200 cm1, characteristic of primary
amines, and new bands at 1020 and 1100 cm1, corresponding to
the symmetric and asymmetric stretching of the O–Si–O groups,
respectively, present in the aminopropyl-trimethoxysilane (APTMS)
chain. Moreover, the band at 3800 cm1 and the one from 3600 to
3400 cm1, due to the stretching vibrations of hydroxyl groups on
the ZnO surface, are less pronounced in the ZnO–NH2 sample with
respect to the pristine ZnO. Since the APTMS moiety links through
hydroxyl groups to the oxide surface (Zn–OH), leading to Zn–O–SiR
bonds, the above-mentioned-observation further confirms the
successful amine functionalization of our ZnO NCs.
The formation of a phospholipidic layer on the ZnO surface
was confirmed by the presence of intense peaks at 2860, 2925
and 1750 cm1 in the ZnO–DOPC spectrum. These peaks are
assigned to the stretching vibrations of CHx and CQO
groups, respectively, present in the phospholipid hydrophobic
tails. Moreover, the characteristic stretching of PQO and P–O
appeared at 1100 and 1230 cm1. The disappearance of the
–OH broad band from 3600 to 3200 cm1 and the attenuation
of the Zn–O bond vibration peak at 440 cm1 further confirm
the success of ZnO interaction with DOPC molecules.
The Z-potential (Fig. 2b) of the three samples was evaluated
in water at different pH values, obtaining different behaviour
and isoelectric points (IEP) depending on the surface properties
of the ZnO NCs and thus on the surface functionalization. For
pristine ZnO, the hydroxyl groups at the surface can protonate
at acidic pH, forming ZnOH2
+ species, whereas at highly basic
pH, ZnO species are formed.20 The measured isoelectric point
(IEP) for pristine ZnO is at pH 9.85, in good agreement with the
literature values.20 Therefore, at lower pH, and in particular at
neutral pH, interesting for biological applications, the pristine
ZnO NCs show a positive Z-potential.
Higher positive values of Z-potential are even observed for
the ZnO–NH2 NCs: actually, at acidic pH the amine groups at
the ZnO surface can protonate, forming –NH3
+ species and the
IEP of these amine-functionalized NCs is shifted to pH 11. In
contrast, an important shift to lower Z-potential values is
obtained for the ZnO–DOPC sample, having an IEP at pH 7.8.
The DOPC phospholipid, showing both a negative phosphate
and a positive amine head group (see the molecule scheme in
Fig. S2 of the ESI†), neutralizes the surface charge of ZnO and
flattens its Z-potential behaviour, with slightly positive values at
acidic pH and slightly negative values at basic pH. The compar-
ison of the Z-potential behaviour of ZnO–NH2 and ZnO–DOPC
with that of pristine ZnO gives a clear confirmation that both
chemical functionalization and coverage by phospholipids of
ZnO NCs worked successfully.
Fig. 2 (a) Fourier Transform-InfraRed (FT-IR) spectra and (b) Z-potential
measurements of the pristine ZnO and functionalized ZnO–NH2 and
ZnO–DOPC NCs.
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It is worth mentioning that, since ZnO is prone to degrada-
tion at acidic pH, here every measurement at each pH value was
followed by a DLS check, still showing a good count rate and
detecting the presence of the nanocrystals.
Further evidence of the lipid bilayer formation of the ZnO
NCs is obtained by fluorescence microscopy co-localization
experiments in wide-field configuration (Fig. 3). The DOPC
lipid formulation was conjugated with 1% Bodipy-DHPE lipid,
showing fluorescence excitation at around 488 nm (Fig. 3a).
Additionally, ZnO NCs functionalized with amino-propyl
groups can be efficiently coupled with Atto550-NHS ester dye,
having fluorescence excitation at 550 nm (Fig. 3b). By merging
the two distinct images, it is worth noting that all the bright
spots in both green and red channels co-localize in the same
position (Fig. 3c and Fig. S3 in the ESI†). Different experiments
were carried out, showing a high percentage of red-labelled NCs
co-localizing with the green-labelled lipids. The conjugation
yield was evaluated to be 95.8%. In addition, since ZnO NCs can
emit in the green channel when excited by UV-light, we have
also imaged the ZnO NCs by exciting them at 340 nm and
collecting their fluorescence in the blue channel (Fig. S3c in the
ESI†). We can actually co-localize in the same position the ZnO
NCs’ fluorescent emission together with the Atto550 dye in the
red channel attached to the ZnO surface and the lipid shell in
the green one, thus shielding the nanocrystals.
The EDS analysis for the three samples (reported in Table S3
of the ESI†) shows that the samples are of ZnO material. In the
case of ZnO–DOPC NCs, the presence of an increased amount
of carbon and a small amount of phosphorus confirms the
presence of lipids.
The colloidal stability of the three ZnO NCs was proven by
DLS (Fig. 4), monitoring their behaviour in various media,
primarily in ethanol and water solutions, then in the physio-
logical simulated media (SBF) and in the cell culture medium
(EMEM) completed with 10% of fetal bovine serum. The aim of
using the last two solutions is to unravel the behaviour of ZnO
NCs and the influence of surface charge and chemistry on the
promotion of colloidal stability in both simulated and bio-
logical media. The SBF is an inorganic buffered salt solution
simulating the composition of human plasma. The DLS beha-
viours versus time (as further shown in Fig. 5) would roughly
simulate what could happen when the above mentioned
Fig. 3 Wide-field fluorescence image of the (a) lipid shell labeled by 1%
Bodipy-DHPE; (b) ZnO–NH2 NCs conjugated with Atto550-NHS ester;
and (c) the merged channels showing complete co-localization. Scale bar:
10 mm.
Fig. 4 Dynamic Light Scattering (DLS) measurements in number % of the
ZnO samples, pristine ZnO NCs (dotted curves), ZnO–NH2 NCs (dashed
curves), and ZnO–DOPC NCs (solid curves) in different media (ethanol,
water, SBF, and EMEM).
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nanocrystals are in contact with plasma fluids, i.e. for a
hypothetical injection into living systems for further therapy
or diagnostic purposes. It is indeed of prominent importance to
avoid aggregation in the bloodstream of nanoparticles con-
ceived to have therapeutic or diagnostic effects on a patho-
logical site of interest in the organisms. Moreover, an efficient
cell uptake and thus therapeutic/diagnostic treatments can be
achieved solely by having well-dispersed nanoparticles, i.e. in
the cell culture medium (EMEM) for in vitro experiments.
Concerning the ZnO–DOPC NCs, the self-assembled lipid
bilayers on the ZnO surface can be disassembled by the
presence of alcoholic solutions;45 thus the DLS measurements
were only carried out in water-based solutions (Fig. 4 from the
second to the fourth panel). We observed that ZnO NCs are well
dispersed in both EtOH (ZnO hydrodynamic diameter: 35 nm)
and water media (ZnO: 44 nm). In contrast, the ZnO–NH2 NCs
show aggregation in ethanol (ZnO–NH2: 59 and 106 nm) and
good dispersion in water solution (ZnO–NH2: 88 nm). It is also
worth noting that the functional layers, both lipidic and amine-
moieties, contribute to a larger hydrodynamic diameter of ZnO
NCs in water solution (with ZnO–DOPC NCs’ mean diameter of
122 nm). In SBF, ZnO and ZnO–NH2 NCs form large aggregates
of micrometer size, whereas ZnO–DOPC NCs remain highly
colloidally dispersed (with a hydrodynamic diameter of 66 nm).
The improved ZnO–DOPC colloidal stability is further confirmed
in EMEM (a narrow hydrodynamic peak at 104 nm). We attribute
this colloidally stable behaviour to the lipid shell stabilization,
shielding the ZnO NCs. In particular, the lipid coating limits the
contact with the ZnO surface preventing possible interactions
with solution’s components. It is also worth noting that in
EMEM also the ZnO–NH2 NCs show a less extent of aggregation
(215 nm) compared to pristine ZnO NCs (1255 nm)
Biostability assays in simulated body fluid and cell culture
media
The previous DLS results showed that the lipid-coating provides
a significant enhancement of colloidal stability in both SBF and
EMEM fluids. Thus, to monitor this behaviour over time,
we recorded in real-time the z-average (mean hydrodynamic
diameter in nm weighed on the scattered light intensity from
the ensemble collection of particles) of ZnO–DOPC NCs and
their uncoated counterparts (ZnO NCs and ZnO–NH2 NCs) in
both SBF and EMEM over time (Fig. 5). It is worth mentioning
that we also tried to record DLS analysis longer than 60 minutes
in SBF; however further measurements did not meet the quality
criteria due to the high instability of the ZnO NC and ZnO–NH2
NC samples in SBF for t 4 60 min. For consistency, the
ZnO–DOPC NCs were not further measured. In contrast,
we can report the data in EMEM also for long time periods
for the three samples.
In Fig. 5a, the mean hydrodynamic size (z-average) of the
pristine ZnO NCs is relatively high, ranging from 3529 nm to
4870 nm, meaning that this sample immediately forms huge
aggregates when exposed to the SBF solution. A visual check
was also performed, noting that pristine ZnO NCs form a white,
fluffy precipitate at the bottom of the measurement cuvette
almost immediately after contact with SBF. A similar behaviour
was observed for the pristine ZnO within the first hour in
EMEM, with z-average ranging from a minimum of 1600 to a
maximum of 1850 nm. Aggregation in both SBF and EMEM
was recorded also for the ZnO–NH2 NCs. In contrast, the ZnO–
DOPC sample remained with a constant and small z-average
(from a minimum value of 194 nm to a maximum of 314 nm) in
both SBF and EMEM solutions for the first hour of the experi-
ments (Fig. 5a and b), accounting for a well-dispersed and
stable sample. When analysing the data in EMEM for long
periods (Fig. 5c) the z-average of ZnO–DOPC maintains a
constant value of about 200–300 nm for the first 72 hours,
increasing up to 500 nm after 25 days. In contrast, the pristine
ZnO NCs account for a decreasing z-average (starting from
1800 nm down to 360 nm) accompanied by a decrease of the
signal count rate, which corresponds to particle precipitation.
The ZnO–NH2 NCs show a constant value at around 1100 nm,
consisting of aggregated but still suspended particles.
FESEM analyses were performed on the three different NCs
after selected time steps (1 h, 72 h, and 25 days) of the
biostability assays in both SBF and EMEM (Fig. 6 and Fig. S4,
S5 in the ESI†).
Both ZnO and ZnO–NH2 NCs show strong aggregation
already from the first hour, as confirmed by the previous DLS
analysis. Both kinds of NCs tend to form spherical aggregates,
Fig. 5 DLS analysis comparing the behaviour of pristine ZnO NCs (dotted
curve) and ZnO–DOPC NCs (solid curve) in terms of mean hydrodynamic
size (z-average) in (a) SBF and (b) EMEM for both short (1 hour) and (c) long
(25 days) time periods.
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whose dimension increases with time. The images of pristine
ZnO NCs in both SBF and EMEM solutions after 1 and 72 hours
still reveal the morphology of the single NCs (see the inset of
Fig. S4a and S5a at the corresponding times in the ESI†). In
contrast, after 25 days in SBF (Fig. 6a and Fig. S4a bottom and
related inset), the sample appears strongly aggregated and the
single NCs are almost indistinguishable. This behaviour is also
evident for ZnO NCs after 25 days in EMEM solution (Fig. 6d) in
which the aggregates are constituted by a smooth matrix that
seems to incorporate the nanocrystals.
Similar considerations can be applied for the ZnO–NH2
samples, forming spherical micrometer-sized aggregates in
SBF after 25 days (Fig. 6b). Large and compact clusters are
formed in EMEM with the presence of precipitates, possibly
derived from the solution (Fig. S5b in the ESI† after 72 h), and a
smooth matrix encapsulating the ZnO–NH2 NCs is visible for
the long time step of 25 days (Fig. 6e).
In contrast with the previous results, the ZnO–DOPC NC
sample shows well distinguishable round-shaped particles even
after biodegradation tests. This behaviour is observed for all
time points in both SBF (Fig. S4 in the ESI†) and EMEM (Fig. S5
in the ESI†). In particular, tiny and well-dispersed nanoparticles
can be observed after 25 days in SBF (Fig. 6c) and until 72 hours
in EMEM (Fig. S5c in the ESI†). Formation of some aggregates
for a longer time period, i.e. 25 days in EMEM (Fig. 6f), can be
observed together with the presence of a soft matrix possibly
Fig. 6 FESEM images of the biostability behaviour of the three ZnO nanocrystals after 25 days assay times in SBF (left column) and EMEM (right column):
(a–d) pristine ZnO, (b–e) ZnO–NH2, and (c–f) lipid-shell coated ZnO–DOPC.
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derived from the medium. Strikingly, the well distinguishable
ZnO–DOPC NCs observed in the FESEM analysis after 72 h and
25 days in both SBF and EMEM media are in fair agreement
with the DLS data. In contrast, it is important to note that in
both ZnO and ZnO–NH2 NC samples after 25 days, the nano-
crystals are no longer distinguishable. In both cases, particle
aggregation, fusion and dissolution occur, as demonstrated
below with further characterization techniques.
The interaction between SBF and EMEM solutions and
nanocrystal surfaces, already supposed when observing FESEM
images, is confirmed by both FT-IR and EDS analyses which
highlight the presence of more elements in addition to the
forecasted Zn and O.
EDS results (reported in Tables S3 and S4 along with SBF
and EMEM compositions in Tables S1 and S2 of the ESI†) show
the presence of carbon, phosphorus, sodium, calcium and
chlorine for all the three samples, i.e. ZnO, ZnO–NH2 and
ZnO–DOPC NCs, at different biostability times in both SBF
and EMEM. For samples in contact with EMEM, the presence
of sulphur, potassium, magnesium and a higher content of
carbon is detected, due to the high amount of proteins, amino
acids and other biomolecules in the cell culture medium. These
data confirm that the matrix incorporating the nanocrystals, in
particular visible for the ZnO and ZnO–NH2 samples in EMEM,
is made of such biomolecules.
Further confirmations are given from FT-IR spectra (Fig. 7),
which show increasing vibrational peaks in terms of frequency
and intensity, with respect to the untreated NCs, at increasing
times of biostability assays. It is, in particular, worth mention-
ing an increasing peak, in all the three kind of samples, at
1045 cm1, ascribed to the stretching vibration of the P–O
bond. As also evidenced by EDS analysis, we assume that
phosphate derivatives (PO4
3) precipitate on these sample
surfaces due to contact with either SBF or EMEM, both contain-
ing phosphate compounds. In particular, at long biostability
times (i.e. 72 hours and 25 days), peaks at 1220 cm1 and
1150 cm1 appear, related to the stretching of PQO bonds,
again attributed to the phosphate groups. Stretching typical of
carbonate groups (C–O) also appears, in accordance with the
increase of carbon content revealed by EDS analysis.
Concerning the ZnO–DOPC, the presence of a phospholipid
layer on the ZnO surface was already confirmed by the presence
of peaks at 2860, 2925 cm1 (stretching vibrations of CHx)
and 1750 cm1 (CQO groups) that maintain a constant inten-
sity at different biostability times in both SBF and EMEM
solutions. Also in both ZnO and ZnO–NH2 samples, the vibra-
tions at 2955, 2915, and 2855 cm1 related to the stretching of
–CH2 and –CH3 groups are already present in the spectra of the
untreated materials, as observed in Fig. 3a. However, longer
biostability times in both SBF and EMEM produce an increase
of these stretching peaks in both ZnO and ZnO–NH2 NCs
accompanied by a constant decrease of the hydroxyl stretching
vibration (–OH) between 3600 and 3000 cm1. Here two different
hypotheses could be made, depending on the solution composi-
tion. In SBF medium, we assume that the oxide surface of the
NCs reacts with some components of the solution, in particular
with TRIS (Tris(hydroxymethyl)aminomethane chlorohydrate),
leading to partial hydrolysis and reaction with methyl groups
of the buffer component, responsible for the increase of the
–CHx stretching vibrations observed in both ZnO and ZnO–NH2
samples. A consequence of this reactive behaviour could also be
partial dissolution of the zinc oxide surfaces, i.e. for both ZnO
and ZnO–NH2 NCs, as further reported below.
In EMEM, we hypothesize that the ZnO and ZnO–NH2 NC
samples aggregate within a soft matrix of proteins and amino
acids and all other biomolecules present in the serum, as
already observed by FESEM. The gradual reduction of –OH
group stretching could account for the interaction of these
groups at the ZnO surface with the bound molecules. These
behaviours can also be associated with the slight dissolution.
In contrast to the case of the pristine ZnO NCs and the
ZnO–NH2 NCs, a strong increase of the –OH stretching band
from 3600 to 3200 cm1 in the ZnO–DOPC NCs is observed
(Fig. 7c). We attribute these variations to the physical adsorption
and coordination with water molecules from both SBF and
EMEMmedia on the phospholipidic layer, positively influencing
the high colloidal stability of the ZnO–DOPC sample in water-
based media, in agreement with the DLS results of Fig. 5.
By comparing the X-ray diffraction patterns of the three ZnO
nanocrystals before and after the biostability assays in both SBF
and EMEM at different time steps (Fig. S6 in the ESI†), one can
notice a slight reduction of the diffraction intensities of the
wurtzite reflections, i.e. (100), (002) and (101) peaks for both
ZnO and ZnO–NH2 NCs. Therefore, we can further support the
previous FT-IR results assuming that partial, but not complete,
hydrolysis and dissolution of the ZnO and ZnO–NH2 surfaces
takes place when they are in contact with SBF and EMEM.
In some samples, we observed the appearance of sharp peaks at
around 321 attributed to NaCl crystals.
In contrast, the diffraction peaks of the ZnO–DOPC NCs
after the different assay times did not decrease, owing to the
high chemical stability of the sample and the maintenance of
the initial crystalline structure.
As a further check of the crystalline quality of ZnO, High
Resolution Transmission Electron Microscopy (HR-TEM) was per-
formed. In Fig. 9 and 10 we show a comparison of each NC
structure before and after prolonged immersion (25 days) in either
SBF or EMEM. All the pictures show the presence of single-
crystalline mono-domains, as confirmed by the Fast Fourier Trans-
form (FFT) in the inset of the pictures, which refers to the white
squared area. These data therefore suggest that the crystalline
integrity of the three different nanocrystals is still preserved after
prolonged immersion in different simulated and biological media.
This result is not in contradiction with the previous FT-IR and XRD
data, where only slight and partial dissolution was hypothesized.
In particular, the HR-TEM images of the ZnO–DOPC sample
(especially in Fig. 10c, left panel) show the NCs immersed in an
amorphous matrix. Considering that the sample was neither
stained nor fixed for this imaging, this amorphous structure
could be attributed to the phospholipidic shell.
The STEM images help to clarify the nanostructures’ aggregation
before and after the biostability treatments. Distinct nanocrystals
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are observed for all the three samples before biostability tests
(Fig. 8a, 9a and 10a), whereas strong aggregation is visible in
particular for the ZnO NC samples (Fig. 8b and c), and to a less
extent for the ZnO–NH2 samples (Fig. 9b and c), after 25 days in
both SBF and EMEM. The as-prepared ZnO–DOPC is characterized
by nanocrystals (Fig. 10a) that, still after 25 days of contact with
simulated buffer and biological fluids, are embedded by a smooth
matrix, attributed to the presence of phospholipids completely
immersing the inorganic crystalline structure (see also Fig. S7 in
the ESI† for other magnified STEM images). All the STEM
measurements are in complete agreement with DLS and FESEM
characterization.
ICP-MS analyses were also carried out on the SBF and EMEM
solutions at each biostability time point, as reported in Fig. 11,
Fig. 7 Fourier-Transform InfraRed (FT-IR) spectra of the (a) pristine ZnO NCs, (b) ZnO–NH2 NCs, and (c) ZnO–DOPC NCs after different time steps of
biostability assays in SBF (left) and EMEM (right).
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monitoring the zinc, phosphorus and calcium elements,
with the last two elements being highly reactive towards the
ZnO surface. In SBF and EMEM solutions, for both ZnO and
ZnO–NH2 NCs, an increase of the Zn
2+ cations is clearly
observed in the first hour from 0 to a maximum of 180 ppm
for ZnO NCs and 121 ppm for ZnO–NH2 NCs in SBF and up to
165 ppm for ZnO NCs and 188 ppm for ZnO–NH2 NCs in
EMEM. These amounts roughly correspond to a range of
dissolution between 7.5 and 11 mol% of zinc with respect to
the initial amount of zinc from the NCs. These trends therefore
underline the slight dissolution of these nanocrystalline struc-
tures in both media, confirming the FT-IR and XRD data
reported above. In addition, a strong reduction of the phos-
phorus content is assessed from SBF (from 40 ppm to 0.5 ppm)
and a bit less in EMEM (from 40 ppm to 10 ppm), confirming
the precipitation of phosphate species on both ZnO and
Fig. 8 HR-TEM, SAED and STEM imaging of the pristine ZnO nanocrystals:
(a) before biostability treatments and in comparison after (b) 25 days in SBF
solution and (c) 25 days in EMEM. The scale bar is 5 nm.
Fig. 9 HR-TEM, SAED and STEM imaging of the amine-functionalized
ZnO–NH2 nanocrystals: (a) before biostability treatments and in compar-
ison after (b) 25 days in SBF solution and (c) 25 days in EMEM. The scale bar
is 5 nm.
Fig. 10 HR-TEM, SAED and STEM imaging of the lipid-shielded ZnO–
DOPC nanocrystals: (a) before biostability treatments and in comparison
after (b) 25 days in SBF solution and (c) 25 days in EMEM. The scale bar
is 5 nm.
Fig. 11 ICP-MS analysis of (a) zinc, (b) calcium, and (c) phosphorus elements
present in SBF and EMEM at different time steps of the biostability assays from
the three ZnO-based NCs.
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ZnO–NH2 sample surfaces already observed with EDS and FT-IR
analyses. In contrast, the level of calcium cations does not
change in SBF for the whole duration of the assays, which is
also confirmed by the almost negligible presence of calcium-
containing species on the ZnO and ZnO–NH2 surfaces in SBF,
found in the previous FT-IR and EDS characterization. Litera-
ture studies report a high degree of interaction between the
phosphate anions and ZnO nanoparticles.47 In silica or
bioglass-based nanomaterial assays in SBF, co-precipitation of
calcium cations with phosphate anions was observed leading to
the formation of the hydroxyapatite compound on the material
surfaces.48–50 However, we believe that in the present case, the
strong interaction between zinc and phosphate is detrimental
for the combination of such anions with Ca2+, and the sole
precipitation of carbonate and phosphate groups on ZnO
and ZnO–NH2 NCs takes place. In addition, no evidence of
hydroxyapatite can be observed (as reported in the X-ray
diffractograms of Fig. S5, evidencing the only presence of
ZnO-related wurtzite phase) in any of the three samples.
Differently, in EMEM the amount of calcium cations slowly
decreases (from 15 ppm to around 5 ppm) when in contact with
the ZnO and ZnO–NH2 NCs, in accordance with EDS analysis
(Table S4, ESI†) detecting the presence of calcium in all
samples.
In remarkable contrast with the previous results, the com-
position of SBF and EMEM solutions in terms of phosphorus
and calcium content does not vary significantly when in contact
with the ZnO–DOPC NCs. In particular, the presence of Zn2+
ions is almost not detectable in the used media for the whole
assay time, i.e. until 25 days. This evidence confirms the
previous results, showing no hydrolysis nor dissolution of the
lipid-coated ZnO samples. An oscillating behaviour, with a
Fig. 12 (a) Fluorescence quantification of ZnO–NH2 and ZnO–NH2–DOPC nanocrystals in HeLa cells after 24, 48 and 72 hours incubation. Data are
expressed as mean  SD of three experiments. P = two-way ANOVA test. (b) 3D representation of ZnO–NH2 nanocrystals uptaken into an HeLa cell.
Intracellular NCs (in red) can be observed through the window opened in the cell membrane region (green). The z-stack images were processed with
Particle_in_Cell-3D Macro. 3D scale bars = 3 mm. Representative fluorescent images of HeLa cell membranes (in green) incubated for 72 hours with
fluorescent (c) ZnO–NH2 and (d) ZnO–NH2–DOPC nanocrystals (in red). Scale bars: 5 mm.
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tendency for reduction, can be just observed for the phos-
phorus content in EMEM for the ZnO–DOPC NCs. This beha-
viour is a clear proof of the precipitation of phosphate groups
on this sample surface, as also previously confirmed by the
FT-IR and EDS analysis.
All these findings support the idea that a phospholipidic
shielding on the ZnO surface is very effective: (i) it enables the
stabilization of the ZnO NCs as a colloidal suspension in
different water and physiological media; (ii) it prevents their
partial degradation, preserving the physico-chemical properties
of the ZnO NCs; and (iii) most importantly, it avoids the release
of potentially cytotoxic Zn2+ cations. In our opinion, these
findings can be possible solely by the formation of a complete
and dense coverage of the phospholipidic bilayer, self-
assembled on the ZnO surface and able to prevent ZnO NCs’
interactions with the surrounding medium.
Internalization and cytotoxicity experiments in HeLa cells
Several studies demonstrated that ZnO NCs’ cytotoxicity and
uptake efficacy are strictly influenced by nanocrystals’ surface
chemistry.19,51,52 To evaluate the effects of different surface
functionalizations, the toxicity and cellular uptake of the
pristine ZnO NCs and the functionalized ones were assessed on
human epithelial carcinoma cells (HeLa). It is worth mentioning
here that the methods used for these cellular studies impose the
use of dye-labelled nanocrystals. As also reported in the Experi-
mental section, we used the amine-functional group at the ZnO NC
surface to covalently bind an ATTO-550 NHS ester dye. Therefore,
any further comparison among the functionalized nanocrystals is
performed between the ZnO–NH2 and ZnO–NH2–DOPC.
The cellular uptake of HeLa cells treated with 18 mg mL1 of
ZnO–NH2 and ZnO–NH2–DOPC nanocrystals was qualitatively
analysed based on fluorescence images after 24, 48 and
72 hours by Spinning Disk microscopy (Fig. 12). After 24 hours
of incubation, the two different types of nanocrystals showed a
comparable uptake rate. After longer incubation times (48 and
72 hours), the DOPC-coated NCs showed a statistically signifi-
cant (Po 0.02) higher intensity of fluorescence possibly related
to their higher internalization (Fig. 12d).
The effects of different concentrations of ZnO, ZnO–NH2
and ZnO–NH2–DOPC nanocrystals on HeLa cell culture for
72 hours are shown in Fig. 13. From a quantitative point of
view, these cytotoxicity data confirmed ZnO nanocrystals’ toxic
effect against HeLa cells only in the case of high NC
concentration.53 Actually, the three kinds of ZnO NCs had no
visible cytotoxic effect on HeLa cells after 72 hours treatment
up to a concentration of about 18 mg mL1. On the contrary,
all of them showed a significant cytotoxic effect when used
at concentrations as high as 90 mg mL1. The data trend of
ZnO–NH2 and ZnO–NH2–DOPC NCs shows a significantly
higher toxicity compared with the ZnO NCs’ treatment, respec-
tively at the concentrations of 36 and 18 mg mL1. This
enhanced cytotoxicity could be partially explained by their
better dispersion in the biological medium compared to
their unfunctionalized counterpart (as reported in the
DLS results of Fig. 4). In this scenario, both ZnO–NH2 and
ZnO–NH2–DOPC NCs would be more easily uptaken by
cancer cells.
In addition, our results suggest that the extent of internali-
zation is not the only parameter affecting cell toxicity. After
72 hours of treatment, ZnO–NH2–DOPC showed a greater degree
of intracellular fluorescence compared to that of the amino-
propyl functionalized ZnO–NH2 NCs although the increased
uptake was not associated to an enhanced cytotoxic effect.26
By considering all the previous results, these data confirm
that intracellular release of zinc ions plays a key role in the
definition of the cytotoxic effect, as already reported in the
literature.40 Our results suggest that the presence of the lipid-
coating limits the access of the ZnO NCs’ surface to the
lysosomal pH, preventing metal ion dissolution. Consequently,
the lipid-shell significantly reduces the cytotoxic effect on the
cultured cell lines, despite the high internalization levels of the
ZnO–DOPC NCs.
Conclusions
We have reported the biostability behaviour in simulated and
biological media, as well as the cell internalization and cyto-
toxicity, of three different kinds of ZnO nanomaterials. In
particular, pristine nanocrystals (ZnO NCs), amino-propyl func-
tionalized ZnO–NH2 NCs and phospholipid-shielded ZnO–DOPC
NCs were studied. The results have shown an important effect of
the surface chemistry and charge on the biostability behaviour at
different time steps.
In particular, we have observed the strong aggregation and
slight dissolution behaviour of both ZnO and ZnO–NH2 NCs
already at short time steps in water-based media, i.e. SBF,
simulating the inorganic composition of human blood, and
EMEM, the cell culture media.
In contrast, we have verified that the successful formation of
a self-assembled phospholipid bilayer on the ZnO nanocrystals’
surface leads to a more biostable nanoconstruct. Actually, the
lipid-shell prevents NCs’ aggregation in water-based media,
improves the colloidal stability over time until 25 days and
avoids NCs’ dissolution into cytotoxic Zn2+ cations. This new
Fig. 13 Cell viability of HeLa cells after 72 hours exposure to ZnO, ZnO–
NH2 and ZnO–NH2–DOPC nanocrystals. The mitochondrial activity was
measured with MTT assay and data were expressed as mean  SD of three
experiments. *p o 0.05, **p o 0.01.
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formulation also improves the internalization of the nano-
crystals into HeLa cancer cells. Strikingly, the higher level of
internalization of ZnO–NH2–DOPC NCs compared to the
uncoated ZnO–NH2 counterpart is not reflected by a higher
cytotoxic effect.
The above reported results give a clear insight into the
behaviour of ZnO nanomaterials in biological media, indicat-
ing that an appropriate surface shielding, i.e. by a phospholipid
bilayer, is fundamental to develop multifunctional ZnO NCs for
therapeutic and bio-imaging applications in cancer cells.
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